Could the next gene therapy manufacturing hub be Cincinnati? A $100M bet says yes

As the investments in cell and gene therapy manufacturing continue to grow across the world, Cincinnati Children’s Hospital and CTI Clinical Trial & Consulting Services have entered a $100 million agreement to produce clinical material locally.